Repare Therapeutics (RPTX) Soars on XenoTherapeutics Takeover Deal: Cash + CVR Offer, Analyst Downgrade and What to Watch on 17 November 2025
Repare Therapeutics shares jumped nearly 30% and traded around $2 after last week’s $78 million takeover deal with XenoTherapeutics. The offer includes about $1.82 per share in cash plus a non-transferable contingent value right tied to future asset sales and milestones. The transaction is expected to close in Q1 2026, pending shareholder and court approval in Québec.
